Healthcare -
Biotechnology - NASDAQ - US
$ 0.1906
1.87 %
$ 12.5 M
Market Cap
-0.13
P/E
Price Target
Average
162.33%
Revenue Forecast
Estimate
186.91%
EBIT
Estimate
52.14%
Net Income
Estimate
44.09%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Lyra Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for LYRA of $0.5 , with forecasts ranging from
a
low of
$0.5 to a high of $0.5 .
LYRA Lowest Price Target
Wall Street Target
0.5 USD
162.33%
LYRA Average Price Target
Wall Street Target
0.5 USD
162.33%
LYRA Highest Price Target
Wall Street Target
0.5 USD
162.33%
REVENUE FORECAST
Revenue Forecast Chart LYRA
EBIT FORECAST
EBIT Forecast Chart LYRA
NET INCOME FORECAST
Net Income Chart LYRA